NCM·Healthcare·$130M·#489 / 520 in Healthcare
GNLX Genelux Corporation
18CRITICAL
CATEGORY BREAKDOWN
GROWTH0
QUALITY0
STABILITY32
VALUATION0
GOVERNANCE53
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
+0.0%
0
> 50% strong
Gross Margin
Revenue retained after direct costs
N/A
0
> 50% strong
Cash Runway
Months of cash at current burn rate
3 months
4
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
14.6%
88
< 25% strong
Price / Sales
Market cap relative to trailing revenue
16254.7x
0
< 3x strong
Rule of 40
Growth rate plus operating margin
-415175
0
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
13.1%
71
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
+17.4%
18
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE GNLX WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when GNLX's score changes by 5+ points.
DATA INFO
Last updated: Jul 1, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.